Evidence map›Paper›PMID 28515325›Full record

ArticleThe Journal of biological chemistry2017

Mutual regulation between Polo-like kinase 3 and SIAH2 E3 ubiquitin ligase defines a regulatory network that fine-tunes the cellular response to hypoxia and nickel.

Cen Li, Soyoung Park, Xiaowen Zhang, Wei Dai, Dazhong Xu

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Cen LiFrom the Department of Pathology, School of Medicine, New York Medical College, Valhalla, New York 10595 and.
Soyoung ParkFrom the Department of Pathology, School of Medicine, New York Medical College, Valhalla, New York 10595 and.
Xiaowen ZhangFrom the Department of Pathology, School of Medicine, New York Medical College, Valhalla, New York 10595 and.
Wei Daithe Department of Environmental Medicine, New York University School of Medicine, Tuxedo, New York 10987.
Dazhong XuFrom the Department of Pathology, School of Medicine, New York Medical College, Valhalla, New York 10595 and dazhong_xu@nymc.edu.
New York Medical College · USNew York University · US

Funding

Plk3 in nickel-induced lung carcinogenesisR21ES023862 · NIEHS · NEW YORK MEDICAL COLLEGE · PI XU, DAZHONG · 2014 to 2015
$432k
NIEHS NIH HHS R21 ES023862
6 · The paper itself

Abstract

Elevated cellular response to hypoxia, which contributes to cell transformation and tumor progression, is a prominent feature of malignant cells in solid tumors. Polo-like kinase 3 (Plk3) is a serine/threonine protein kinase known to inhibit the cellular response to hypoxia and tumorigenesis. Nickel compounds are well-established human carcinogens that induce tumorigenesis partly through their hypoxia-mimicking effects. Despite previous research efforts, the role of Plk3 in the hypoxic response induced by hypoxia or nickel is not completely understood. Here, we show that NiCl

Indexed as

A549 CellsCell HypoxiaGene Expression Regulation, EnzymologicGene Expression Regulation, NeoplasticHumansNeoplasm ProteinsNeoplasmsNickelNuclear ProteinsPolo-like KinasesProtein Serine-Threonine KinasesProteolysisSeven in Absentia ProteinsTumor Suppressor ProteinsUbiquitin-Protein LigasesUbiquitin ThiolesteraseNeoplasm ProteinsNickelnickel chlorideNuclear ProteinsPLK3 protein, humanPolo-like KinasesProtein Serine-Threonine KinasesSeven in Absentia ProteinsTumor Suppressor ProteinsUbiquitin-Protein LigasesUbiquitin ThiolesteraseUSP28 protein, humancarcinogenesisE3 ubiquitin ligasehypoxialungnickelplk3SIAH2tumor suppressor geneubiquitinUSP28

Identifiers

PMID28515325
PMCPMC5500808
OpenAlexW2615667345

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.